I agree that this site is using cookies. You can find further informations here.
X
Pudlarz, T.
8  results:
Search for persons X
?
1

234P Do we need molecular profiling in patients with squamo..:

Smolenschi, C. ; Sharaf, R. ; Hollebecque, A....
Annals of Oncology.  35 (2024)  - p. S100-S101 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pancreatic adenocarcinoma third line systemic treatments: a..:

Gueiderikh, A. ; Tarabay, A. ; Abdelouahab, M....
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

291P Tumor biology, treatment patterns, and survival outcom..:

Turpin, A. ; Pudlarz, T. ; Antoun, L....
Annals of Oncology.  35 (2024)  - p. S123 , 2024
Link: https://doi.org/10.1016/..
 
?
4

340P Molecular profiling in pancreatic cancers: Therapeutic..:

Tarabay, A. ; Boileve, A. ; Smolenschi, C....
Annals of Oncology.  35 (2024)  - p. S142 , 2024
Link: https://doi.org/10.1016/..
 
?
5

338P Heads or tails? In-depth analysis of pancreatic cancer..:

Fernandes, A. ; Lambert, A. ; Tarabay, A....
Annals of Oncology.  35 (2024)  - p. S142 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Codon-specific KRAS mutations predict survival in advanced ..:

Boilève, A. ; Rousseau, A. ; Hilmi, M....
ESMO Gastrointestinal Oncology.  3 (2024)  - p. 100030 , 2024
Link: https://doi.org/10.1016/..
 
?
7

172P Early impact of a personalised cancer interception pro..:

Veron, L. ; Aupomerol, M. ; Ouali, K....
ESMO Open.  8 (2023)  1 - p. 101449 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivoluma..:

André, T ; Tougeron, D ; Piessen, G...
info:eu-repo/semantics/altIdentifier/doi/10.1200/JCO.22.00686.  , 2023
Link: https://hal.science/hal-..
 
1-8